NELARABINE Pharmacologic Class Indexing
- Class set ID
- 6eb52f25-1a2a-4880-bda9-6ebd2e765870
- Version
- 2
- Effective date
- 20180813
- Type
- Indexing - Pharmacologic Class
Mapped DailyMed Labels#
Label, Manufacturer, Effective table| Label | Manufacturer | Effective | SPL version |
|---|
| These highlights do not include all the information needed to use NELARABINE INJECTION safely and effectively. See full prescribing information for NELARABINE INJECTION. NELARABINE injection, for intravenous use Initial U.S. Approval: 2005 | Amneal Pharmaceuticals LLC | Amneal Oncology Private Limited | 20260211 | 8 |
| These highlights do not include all the information needed to use NELARABINE INJECTION safely and effectively. See full prescribing information for NELARABINE INJECTION. NELARABINE injection, for intravenous use Initial U.S. Approval: 2005 | Meitheal Pharmaceuticals Inc | Kindos Pharmaceuticals Co., Ltd. | 20251001 | 4 |
| These highlights do not include all the information needed to use NELARABINE INJECTION safely and effectively. See full prescribing information for NELARABINE INJECTION. NELARABINE injection, for intravenous use Initial U.S. Approval: 2005 | Shorla Oncology Inc. | Shorla Pharma Ltd. | AqVida GmbH | 20250723 | 6 |
| These highlights do not include all the information needed to use NELARABINE INJECTION safely and effectively. See full prescribing information for NELARABINE INJECTION. NELARABINE injection, for intravenous use Initial U.S. Approval: 2005 | Alembic Pharmaceuticals Inc. | Alembic Pharmaceuticals Limited | 20250708 | 4 |
| These highlights do not include all the information needed to use NELARABINE INJECTION safely and effectively. See full prescribing information for NELARABINE INJECTION. NELARABINE injection, for intravenous use Initial U.S. Approval: 2005 | Zydus Pharmaceuticals USA Inc. | Zydus Lifesciences Limited | 20250416 | 5 |
| These highlights do not include all the information needed to use NELARABINE INJECTION safely and effectively. See full prescribing information for NELARABINE INJECTION. NELARABINE injection, for intravenous use Initial U.S. Approval: 2005 | Gland Pharma Limited | 20250410 | 6 |
| These highlights do not include all the information needed to use NELARABINE INJECTION safely and effectively. See full prescribing information for NELARABINE INJECTION. NELARABINE injection, for intravenous use Initial U.S. Approval: 2005 | Zydus Pharmaceuticals USA Inc. | Zydus Lifesciences Limited | 20250407 | 6 |
| These highlights do not include all the information needed to use ARRANON safely and effectively. See full prescribing information for ARRANON. ARRANON ® (nelarabine) injection, for intravenous use Initial U.S. Approval: 2005 | Sandoz Inc | 20250331 | 4 |
| These highlights do not include all the information needed to use ARRANON safely and effectively. See full prescribing information for ARRANON. ARRANON ® (nelarabine) injection, for intravenous use Initial U.S. Approval: 2005 | Novartis Pharmaceuticals Corporation | 20250331 | 10 |
| These highlights do not include all the information needed to use NELARABINE INJECTION safely and effectively. See full prescribing information for NELARABINE INJECTION. NELARABINE injection, for intravenous use Initial U.S. Approval: 2005 | Dr. Reddy's Laboratories, Inc. | Dr. Reddy's Laboratories Limited | 20250329 | 7 |
| These highlights do not include all the information needed to use NELARABINE INJECTION safely and effectively. See full prescribing information for NELARABINE INJECTION. NELARABINE injection, for intravenous use. Initial U.S. Approval: 2005 | XGen Pharmaceuticals DJB, Inc. | 20241218 | 2 |
| These highlights do not include all the information needed to use NELARABINE INJECTION safely and effectively. See full prescribing information for NELARABINE INJECTION. NELARABINE injection, for intravenous use Initial U.S. Approval: 2005 | Alembic Pharmaceuticals Limited | 20240807 | 2 |
| These highlights do not include all the information needed to use NELARABINE INJECTION safely and effectively. See full prescribing information for NELARABINE INJECTION. NELARABINE injection, for intravenous use Initial U.S. Approval: 2005 | Sagent Pharmaceuticals | 20240528 | 1 |
| These highlights do not include all the information needed to use Nelarabine Injection safely and effectively. See full prescribing information for Nelarabine Injection. Nelarabine Injection, for intravenous use Initial U.S. Approval: 2005 | Nexus Pharmaceuticals LLC | 20231227 | 5 |
| These highlights do not include all the information needed to use NELARABINE INJECTION safely and effectively. See full prescribing information for NELARABINE INJECTION. NELARABINE injection, for intravenous use Initial U.S. Approval: 2005 | Novadoz Pharmaceuticals LLC | MSN LABORATORIES PRIVATE LIMITED | 20230516 | 1 |
| NELARABINE INJECTION | Zydus Lifesciences Limited | 20221105 | 2 |